President Trump signed a $1.2 trillion spending package this week, provisions of which could radically change the way ...

Often in the policy realm (and especially in the health space), major reforms are tackled in both the legislative and regulatory arenas. Congress ...

Guidance for 2026 EPS increased from a reaffirmed 2025 outlook of at least $29.60 per share in Q3 to at least $30.25 per share for 2026 in Q4.

Regenerative medicine is shifting healthcare beyond aesthetics as doctors explain how cellular therapies restore healing, wellness, and long term health.

Q2 2026 earnings call recap: revenue up 12%, near-record 39% Senior EBITDA margin, but FY26 guidance cut on PBM/carrier ...

Cigna is hoping the settlement it reached with regulators this week paired with recent legislation will mollify calls to ...

Cigna Group’s shares are up about 3% in trading Thursday, showing that investors don’t think the recent round of changes out of Washington will fundamentally alter the company’s outlook. Cigna is the ...

Pharmacists meet with lawmakers to express opposition to bill they say would result in closure of 134 Tennessee locations ...

Cigna posted $1.2 billion in profit for the fourth quarter of 2025, down slightly from the prior year but still enough to surpass Wall Street analysts' predictions. | Cigna posted $1.2 billion in ...

1. FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients. United States Federal ...

The Federal Trade Commission has announced what it called a “landmark settlement” with Express Scripts over insulin pricing.

The Federal Trade Commission (FTC) has secured a landmark settlement with one of the nation’s largest pharmacy benefit ...